Cargando…

Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response

Detalles Bibliográficos
Autores principales: Zheng, Yongqiang, Pan, Yi‐Qian, Liao, Kun, Yu, Kai, Wu, Qinian, Chen, Yanxing, Deng, Yuqing, Sun, Hui, Pu, Hengying, Ju, Huai‐Qiang, Xu, Rui‐Hua, Liu, Ze‐Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689971/
https://www.ncbi.nlm.nih.gov/pubmed/38037528
http://dx.doi.org/10.1002/ctm2.1501
_version_ 1785152463597207552
author Zheng, Yongqiang
Pan, Yi‐Qian
Liao, Kun
Yu, Kai
Wu, Qinian
Chen, Yanxing
Deng, Yuqing
Sun, Hui
Pu, Hengying
Ju, Huai‐Qiang
Xu, Rui‐Hua
Liu, Ze‐Xian
author_facet Zheng, Yongqiang
Pan, Yi‐Qian
Liao, Kun
Yu, Kai
Wu, Qinian
Chen, Yanxing
Deng, Yuqing
Sun, Hui
Pu, Hengying
Ju, Huai‐Qiang
Xu, Rui‐Hua
Liu, Ze‐Xian
author_sort Zheng, Yongqiang
collection PubMed
description
format Online
Article
Text
id pubmed-10689971
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106899712023-12-02 Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response Zheng, Yongqiang Pan, Yi‐Qian Liao, Kun Yu, Kai Wu, Qinian Chen, Yanxing Deng, Yuqing Sun, Hui Pu, Hengying Ju, Huai‐Qiang Xu, Rui‐Hua Liu, Ze‐Xian Clin Transl Med Letter to the Journal John Wiley and Sons Inc. 2023-11-30 /pmc/articles/PMC10689971/ /pubmed/38037528 http://dx.doi.org/10.1002/ctm2.1501 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Journal
Zheng, Yongqiang
Pan, Yi‐Qian
Liao, Kun
Yu, Kai
Wu, Qinian
Chen, Yanxing
Deng, Yuqing
Sun, Hui
Pu, Hengying
Ju, Huai‐Qiang
Xu, Rui‐Hua
Liu, Ze‐Xian
Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response
title Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response
title_full Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response
title_fullStr Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response
title_full_unstemmed Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response
title_short Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response
title_sort pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response
topic Letter to the Journal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689971/
https://www.ncbi.nlm.nih.gov/pubmed/38037528
http://dx.doi.org/10.1002/ctm2.1501
work_keys_str_mv AT zhengyongqiang pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT panyiqian pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT liaokun pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT yukai pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT wuqinian pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT chenyanxing pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT dengyuqing pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT sunhui pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT puhengying pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT juhuaiqiang pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT xuruihua pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse
AT liuzexian pancancerlandscapeoftumourendothelialcellspinpointsinsulinreceptorasanovelantiangiogenictargetandpredictsimmunotherapyresponse